Enjoy complimentary customisation on priority with our Enterprise License!
The protein A resin market size is forecast to increase by USD 721.6 million at a CAGR of 10.03% between 2023 and 2028. The market is experiencing significant growth due to the increasing demand for monoclonal antibodies (mAbs) and biosimilars in various applications, including diagnostics, therapeutics, and research. Protein A resin is a crucial component in the production of mAbs, making it an essential player in the biopharmaceutical industry. Additionally, the rising trend of biosimilars, which are cost-effective alternatives to branded biologics, is further boosting the market's growth. However, the lack of skilled professionals in the field of protein A resin technology poses a significant challenge to market expansion. To address this challenge, companies are investing in training and education programs to develop a skilled workforce and improve the overall efficiency of protein A resin production processes.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.